SEARCH RESULT

Total Matching Records found : 257

Patients' groups voice patent fears

-The Telegraph New Delhi: Health and patients' rights groups have called on the government to resist American pressure that they claimed was aimed at weakening safeguards in India's patent laws that allow drug companies to sell inexpensive generic medicine. Health activists representing patients' rights said they were concerned that bilateral talks on intellectual property rights, to feature during US President Barack Obama's visit to India beginning this weekend, may be rigged against...

More »

Obama visit: civil society appeals to Modi not to succumb to US pressure on IP laws -Kundan Pandey

-Down to Earth US actions jeopardise India's pro-poor patent laws that promote generic drugs production, says online global petition More than 75,000 people have requested Prime Minister Narendra Modi not to succumb to US pressure on Intellectual Property Rights (IP). With trade and intellectual property rights featuring prominently in the agenda of US president Barak Obama's India visit, civil society groups have expressed concern that talks on these issues are designed to make...

More »

Govt may negotiate price of drugs before market entry -Sushmi Dey

-The Times of India NEW DELHI: The government may negotiate prices of patented medicines with their manufacturers before allowing pharmaceutical companies to launch them in India. The move, a first of its kind, is also likely to be applied on patented drugs that are already being sold in the country, an official source said. An inter-ministerial committee, evaluating the mechanism to negotiate prices of patented medicines, has recently sought detailed information about...

More »

Fillip to cheaper hepatitis C drug -GS Mudur

-The Telegraph New Delhi: India's patent regulating agency today rejected a US company's patent claim on a drug to treat hepatitis C, raising hopes that generic drug makers could now produce cheaper versions of the medicine. The Indian Patents Controller has denied a patent to sofosbuvir from Gilead, a US biopharmaceutical company that had last year pledged to make the oral drug available in India and 90 other developing countries at $900...

More »

MDG-led healthcare policy not comprehensive, says report -Jyotsna Singh

-Down to Earth In a Union budget wish list, civil society organisations call for course correction in policy and improving access to healthcare in India The government's focus on improving health indicators stated in the Millennium Development Goals (MDGs) has worked against the aims of universal health coverage, said experts at the National Convention on Union Budget 2015-16 held in Delhi on January 8 and 9. They recommended that the focus must...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close